Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +36.1% | -1947.2% | 2 / 3 | -3.3% | +3.62 pp | +2.13 pp | -21.3% | 1.71 | — | 585 | −3,3% | −24,3 | +36,1% | — | -3.78 | — |
| Pts | 8 | 0 | 8 | 0 | 12 | 12 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 11.200 (close price on 2026-10-15)EPS (TTM): −2.106,3
Financial charts
1.Revenue & growth
VND bn585Q2/26
1.Revenue & growth
VND bn585Q2/26
2.Profit & growth
VND bn-24,3Q2/26
3.Profit mix (Penman)
VND bn-117Q2/26
4.Margins & cost structure
%0.7%Q2/26
5.Returns & cash cycle
% · days-0.5%Q2/26
6.Earnings quality & cash
VND bn-38,8Q2/26
7.Asset structure
VND bn1.805Q2/26
8.Funding & debt health
VND bn · times1.805Q2/26
9.Revenue backlog
VND bn49,0Q2/26
10.Valuation
times · %-5,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-395Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26